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Abstract
Objectives: To describe the findings and evaluate appropriateness of a carotid artery study
including the measurement of IMT, the presence of atherosclerotic plaque, and their correlation
with cardiovascular risk factors.
Methods: 555 patients (220 men; 67.06 ± 12.44 years) were included in the study. 120 patients
(21.62%) presented carotid plaque: 108 (19.45%) in patients with at least one risk factor and 12
(2.1%) in patients without risk factors. With respect to appropriateness of the present studies: 65%
were appropriate, 22% were uncertain and 13% were inappropriate. The IMT medians were higher
in males (0.0280; 95% CI, 00.82 to 0.478; p = 0.0057) and in hypertensive patients (0.391; 95% CI,
0.0190 to 0.0592; p = 0,001). There was a linear increase in mean IMT for each year increased in
age (0.0059; 95% CI; 0.0050 to 0.0067). Carotid plaque was more frequent in patients with CAD
(p = 0.0002), diabetes (p = 0.024) and hypertension (p = 0.036).
Conclusion: Assessment of carotid arteries identified increased incidence of plaque in patients
with CAD, diabetes and hypertension. IMT was increased in older patients, hypertensive patients
and males. Forty-five percent of the patients were studied based on uncertain and inappropriate
reasons.
Introduction
It has been proven that the atherosclerotic changes in the
carotid artery mirror general atherosclerosis. Ultrasound
measurements of IMT and plaque occurrence in the
carotid arteries are important not only for the assessment
of structural alterations but also because the extent of
atherosclerosis in these vessels reflects the severity of arte-
rial damage in other vascular territories [1]. Epidemiolog-
ical studies and clinical trials have shown that carotid
artery intima-media thickness can identify prevalent and
incident cardiovascular disease (CVD) events, and pro-
gression and regression of atherosclerosis [2]. Intima-
media thickness (IMT) of the carotid arteries is increas-
ingly used in clinical trials as an important risk marker to
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investigate normal aging and preclinical atherosclerosis
[3]. Several studies demonstrated that carotid IMT is sig-
nificantly associated with risk for myocardial infarction,
stroke, death from coronary artery disease, or a combina-
tion of these events [4]. Interestingly, in daily clinical
practice, with the diffusion of knowledge and the educa-
tion of public opinion, many physicians request carotid
ultrasound studies even in patients without cardiovascu-
lar risk. We carried out this study to describe the findings
and evaluate the appropriateness of carotid artery studies
with ultrasound, including the measurement of ITM; the
presence or not of atherosclerotic plaque; and their corre-
lation with traditional cardiovascular risk factors in rou-
tine exams from our Doppler vascular laboratory.
Methods
Patients
Five hundred eight patients (229 men and 351 women;
mean age 67.06 ± 12.44 years) who underwent a carotid
artery ultrasound in our Doppler vascular laboratory were
screened for carotid plaque and IMT measurement. Infor-
mation on demographic characteristics and risk factors
were collected using a structured questionnaire. Indica-
tion to perform the exam was recorded based on the refer-
ring physician's request. In addition, patients were asked
about the indication for the exam and the presence or not
of hypertension, diabetes mellitus, dyslipidemia, coro-
nary artery disease, stroke and current smoking. Hyperten-
sion was defined by a history of treated hypertension.
Smoking history was coded as never or current smoker.
Subjects were classified as diabetics when treated for insu-
lin-dependent or non-insulin-dependent diabetes. The
use of lipid-lowering drugs was assessed and the history of
myocardial infarction, angioplasty, or coronary artery by-
pass surgery was recorded. A positive coronary artery dis-
ease (CAD) history was defined by the presence of any of
these diseases. History of stroke or transient ischemic
attacks was obtained for all cases. In addition, we classi-
fied the studies according to three categories: appropriate,
inappropriate and uncertain. Appropriate studies were
those for which patients had one or more risk factors;
uncertain studies were those for which patients had non-
specific symptoms; and the studies for which patients had
no risk factors or symptoms were considered to be inap-
propriate. The patient's baseline characteristics and the
indications for carotid ultrasound based on medical
request or patient's information are displayed in Tables 1
and 2.
Ultrasound measurements
Measurements were made with a high-resolution B-mode
ultrasonography (Philips Medical Systems' HD11 plat-
form) with a broadband width linear array transducer L
3–12 MHz. Sonography and readings were carried out by
trained and certified sonographers. Measurements of IMT
were take on the distal 10 mm of both right and left com-
mon carotid artery in the far wall. Five determinations
were conducted on each side and the average measure-
ment was used for the IMT. An artery was classified as
being affected by plaque if there was a localized thicken-
ing > 1.5 mm that did not uniformly involve the whole
left or right carotid artery with or without flow distur-
bance. The vascular ultrasonographist identified plaques
on common, internal and external carotids at the time of
ultrasound measurement.
Statistical analysis
Categorical variables were expressed as percentages and
continuous variables were expressed as mean ± SD, with a
95% confidence interval (CI) and a significance level of
5%. Multiple linear regression analysis was used to assess
the association between cardiovascular risk factors and
IMT. Age and sex were used as control variables. Twenty-
five IMT measurements identified as possible outliers or
influential cases were eliminated using the DFFITS proce-
dure. χ2 test with Yates correction was used to correlate
each risk factor and the presence of plaque. The regression
logistic model was used to assess all variables with respect
to the presence of plaque. Statistical significance was indi-
Table 1: Patient's baseline characteristics
Patients with risk factors (N/%) 451 (81.26%) Carotid plaque
Sex (M/F) 175/276
Age (y ± SD) 67.6 ± 11.7
All patients 108 (19.45%)
History of hypertension (N/%) 333 (73.8%)
History of dyslipidemia (N/%) 249 (55.2%)
History of diabetes mellitus (N/%) 100 (22.2%)
Cardiovascular history (N/%) 71 (15.7%)
Current smoking (N/%) 65 (14.4%)
Patients without risk factors (N/%) 104 (18.73%) 12 (2.1%)
Sex (M/F) 42/62
Age (y ± SD) 64.6 ± 15.1Cardiovascular Ultrasound 2008, 6:52 http://www.cardiovascularultrasound.com/content/6/1/52
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cated by a value of p < 0.05. Analyses were performed
using Statistica/W version 5.1 (StatSoft, Tulsa, Okla.).
Results
A total of 555 patients were analyzed. Four hundred fifty-
one (178 men; 67.6 ± 11.7 years) had at least one risk fac-
tor. One hundred four patients (42 men; 64.6 ± 15.1
years) had no risk factor. The appropriateness of the stud-
ies is displayed on figure 1. Risk stratification or "check-
up" was the main indication for carotid ultrasound study
in most patients (55.85%) even in subjects with no risk
factor at all, followed by dizziness or vertigo (12.79%).
Hypertension was present in 73.8%; dyslipidemia in
55.2%; diabetes in 22.2%; coronary artery disease (CAD)
in 15.7%; and current smoking in 14.4%. One hundred
twenty patients (21.62%) had carotid plaque: 108
(19.45%) in patients with at least one risk factor and 12
(2.1%) in patients without risk factors. (Tables 1 and 2).
The IMT medians were higher in males (0.0280; 95% CI,
00.82 to 0.478; p = 0.0057) and in patients with hyperten-
sion (0.391; 95% CI, 0.0190 to 0.0592; p = 0.001). There
was a linear increase in mean IMT for each year increased
in age (0.0059; 95% CI; 0.0050 to 0.0067). (Table 3).
(Figure 2). Other risk factors did not influence IMT meas-
urements. Plaque occurrence tended to influence IMT
measurement (p = 0.067). Plaque was more present in
patients with CAD (p = 0.0002), with diabetes (p = 0.024),
and with hypertension (p = 0.036). There was no signifi-
cant difference in patients with dyslipidemia (p = 0.158)
or current smokers (p = 0.766). (Data not shown).
Discussion
The Mannhein Carotid IMT Consensus [3,5] and the ASE
Consensus Statement [4] recommended IMT measure-
ments for patients at intermediate CVD risk and in sub-
jects with the following clinical circumstances: (1) family
history of premature CVD in first-degree relatives; (2)
individuals younger than 60 years old with severe abnor-
malities in a single risk factor who otherwise would not be
candidates for pharmacotherapy; (3) women younger
than 60 years of age with at least two CVD risk factors; and
(4) in all epidemiological and interventional trials dealing
with vascular diseases to better characterize the popula-
tion investigated. However, carotid ultrasound and the
assessment of IMT are highly requested today by most
physicians, in particular by cardiologists. In the present
study, the "check-up" was the main indication for carotid
ultrasound study, followed by dizziness or vertigo, even in
patients with no risk factors. The risk stratification of an
individual patient without clinically apparent atheroscle-
rosis (primary prevention) is oftentimes complex. There
are patent scenarios in which an individual is judged to be
at low risk of future CV events by traditional risk stratifica-
tion scoring, however, because of a young age, the pres-
ence of a strikingly abnormal single risk factor, or of an
emerging risk factor, the incremental information pro-
vided by a carotid IMT may more accurately assess this risk
[6]. The ASE Consensus Statement also recommends the
use of a semi-automated border detection program with
validated accuracy for assessment of IMT [4], but since
most vascular labs do not have an automated system to
determine IMT and vascular age, the sonographers regu-
larly use manual reading techniques. In vascular labora-
tory daily routine, the ultrasonographist easily visualizes a
normal and an irregular intima-media layer in carotid ves-
sels or atherosclerotic plaque. (Figure 3). Porter et al [7]
showed that dynamic range, gain and probe distance sig-
nificantly alter lumen diameter and IMT measurements
Table 2: Indications for carotid ultrasound study (N/%)
Patients with risk factors 451 (81.26%)
Check-up 238 (51.8%)
Dizziness or vertigo 60 (13.1%)
Syncope 35 (7.6%)
Stroke 30 (6.5%)
Preoperatory evaluation 16 (3.8%)
Transient amnesia or disorientation 14 (3.1%)
Previous carotid artery disease 9 (1.9%)
Unspecific symptoms 56 (12.2%)
Patients without risk factors 104 (18.73%)
Check-up 72 (71.2%)
Dizziness or vertigo 11 (10.8%)
Syncope 3 (3.1%)
Stroke 5 (5.4%)
Preoperatory evaluation 1 (1%)
Transient amnesia or disorientation 1 (1%)
Previous carotid artery disease 2 (2.1%)
Unspecific symptoms 6 (6.1%)
Table 3: Ultrasound measurements (95% CI)
Variable Controls P value Lower limit Upper limit
Sex 0.280 0.0057 0.0082 0.0478
Age 0.0059 < 0.001 0.0050 0.0067
Hypertension 0.0391 < 0.001 0.0190 0.0592
Diabetes 0.0103 0.4251 0.0358 0.0151
Current smoking 0.0095 0.5293 0.0201 0.0390
Dyslipidemia 0.0081 0.4109 0.0273 0.0112
CAD 0.0136 0.3636 0.0430 0.0158Cardiovascular Ultrasound 2008, 6:52 http://www.cardiovascularultrasound.com/content/6/1/52
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made even using image analysis software. In the present
study, we made 5 consecutive measurements for IMT in
each common carotid artery in order to minimize the
errors. Interestingly, we found atherosclerotic plaque in
only 19.45% of patients with at least one risk factor and
in only 2.1% of patients without any risk factor. It is clear
that the prognostic performance of a method is heavily
related to the type of population. The present study
included not only patients indicated by a cardiologist but
also the general population, referred by other medical
specialities such as homeopathic medicine, gerontology
and internal medicine, thus including some patients with
no cardiovascular risk at all. We also considered cardiac
and cerebrovascular events. As in previous studies [1,8,9],
we found higher values of IMT in hypertensive subjects,
however with respect to other risk factors, we did not find
any influence on this measurement. The progression of
atherosclerotic disease may occur at different rates and as
a result of different risk factors in each vascular bed [10].
We also found higher values of IMT in males and older
patients. In view of all these findings, some questions
arise, for example: 1 – What information should we give
to the referred physician?; 2 – What will they do in a
totally asymptomatic patient with no risk factor? Ultra-
sonographists, therefore, should be precise in their report
regarding the presence or not of plaque and the measure-
ment of IMT. These findings could change risk stratifica-
tion for asymptomatic subjects and their primary
physician should be aware of this possibility. In addition,
carotid IMT has proven to be a powerful tool for assessing
cardiovascular risk. Atherosclerosis is not a single disease
entity, but a process consisting of the responses to numer-
ous insults to the endothelium and smooth muscle cells
of the arterial wall. This "response-injury" hypothesis is
formulated by numerous observations in humans and
animals, and the entire process from the earliest recogniz-
able lesion (fatty streak) to advanced lesions in atheroscle-
rosis (fibrous plaques) is tightly linked to an
inflammatory response [7,11-18]. If, in a patient with no
risk factor, we find an increased IMT or a small carotid
plaque the personal physician should most likely inquire
about inflammatory markers. Finally, there are several
studies [19-21] evaluating the prognoses of increased IMT
and raise the question of whether or not one should treat
this condition. We hope to soon understand the signifi-
cance of an increased IMT or the presence of small plaque
in healthy subjects.
Conclusion
In a routine vascular laboratory the assessment of carotid
arteries identified increased incidence of plaque in
patients with CAD, diabetes and hypertension. In addi-
Appropriateness graphic Figure 1
Appropriateness graphic.
Dispersion diagram between IMT and age (0.0059; 95%  CI,0.0050 to 0.0067) Figure 2
Dispersion diagram between IMT and age (0.0059; 
95% CI,0.0050 to 0.0067).
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Carotid intima media thickness Figure 3
Carotid intima media thickness. A Increased and irregu-
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tion, carotid IMT was increased in hypertensive patients
and males. Older patients presented higher values of
carotid IMT. Forty-five percent of the studies were catego-
rized as uncertain and inappropriate.
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